Yang Hao,Shu Qiang,Guo Xiaodong.Recent advances in the treatment of infantile hemangiomas[J].Journal of Clinical Pediatric Surgery,,18():640-645.[doi:10.3969/j.issn.1671-6353.2019.08.005]
Click Copy

Recent advances in the treatment of infantile hemangiomas

References:

1 Munden A,Butschek R,Tom WL,et al.Prospective study of infantile haemangiomas:incidence,clinical characteristics and association with placental anomalies[J].Br J Dermatol,2014,170(4):907-913.DOI:10.1111/bjd.12804.
2 Guo S,Ni N.Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution[J].Arch Ophthalmol,2010,128(2):255-256.DOI:10.1001/archophthalmol.2009.370.
3 Borok J,Gangar P,Admani S,et al.Safety and efficacy of topical timolol treatment of infantile haemangioma:a prospective trial[J].Br J Dermatol,2018,178(1):e51-e52.DOI:10.1111/bjd.15865.
4 Droitcourt C,Kerbrat S,Rault C,et al.Safety of oral propranolol for infantile hemangioma[J].Pediatrics,2018,141(6):e20173783.DOI:10.1542/peds.2017-3783.
5 Ge J,Zheng J,Zhang L,et al.Oral propranolol combined with topical timolol for compound infantile hemangiomas:a retrospective study[J].Sci Rep,2016,6:19765.DOI:10.1038/srep19765.
6 Puttgen K,Lucky A,Adams D,et al.Topical timolol maleate treatment of infantile hemangiomas[J].Pediatrics,2016,138(3):e20160355.DOI:10.1542/peds.2016-0355.
7 Zheng L,Li Y.Effect of topical timolol on response rate and adverse events in infantile hemangioma:a meta-analysis[J].Arc Dermatol Res,2018,310(4):261-269.DOI:10.1007/s00403-018-1815-y.
8 王俞明,耿峰,查宗煜,等.0.5%噻吗洛尔溶液局部治疗婴幼儿血管瘤的疗效观察[J].组织工程与重建外科杂志,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.Wang YM,Geng F,Zha ZY,et al.Effectiveness of 0.5% solution of topical timolol maleate for infantile hemangiomas[J].Journal of Tissue Engineering & Reconstructive Surgery,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.
9 Frommelt P,Juern A,Siegel D,et al.Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma[J].Pediatr Dermatol,2016,33(4):405-414.DOI:10.1111/pde.12869.
10 Rocco R,Alegre N,Pozner R,et al.Selective hemangioma cell dysfunction and apoptosis triggered by in vitro,treatment with imiquimod[J].Toxicol Lett,2018,288:82-88.DOI:10.1016/j.toxlet.2018.01.016.
11 Hu L,Huang HZ,Li X,et al.Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma[J].Dermatology,2015,230(2):150-155.DOI:10.1159/000369164.
12 Nguyen J,Fay A.Pharmacologic therapy for periocular infantile hemangiomas:a review of the literature[J].Semin Ophthalmol,2009,24(3):178-184.DOI:10.1080/08820530902805602.
13 Couto JA,Greene AK.Management of problematic infantile hemangioma using intralesional triamcinolone:efficacy and safety in 100 infants[J].J Plast Reconstr Aesthet Surg,2014,67(11):1469-1474.DOI:10.1016/j.bjps.2014.07.009.
14 杨耀武,郑家伟,孙沫逸,等.聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志,2018,16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.Yang YW,Zheng JW,Sun YM,et al.Expert consensus on the treatment of oral and maxillofacial hemangiomas and vascular malformations by lauromacrogol sclerotherapy[J].China Journal of oral and Maxillofac Surgery,2018,16(3):275-278.DOI:0.19438/j.cjoms.2018.03.017.
15 蔡仁慧,吕萍.聚桂醇泡沫硬化剂治疗婴幼儿血管瘤79例临床观察[J].中国皮肤性病学杂志,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.Cai RH,Lv P.Efficacy of lauromacrogol foam sclerotherapy in the treatment of 79 cases of infantile hemangioma[J].Chin J Derm Venereol,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.
16 Gao Z,Zhang Y,Li W,et al.Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations:a meta-analysis[J].Dermatol Ther,2017,31(1):e12568.DOI:10.1111/dth.12568.
17 Qiu Y,Lin X,Ma G,et al.Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas:a long-term follow-up[J].Pediatr Dermatolo,2015,32(2):188-191.DOI:10.1111/pde.12422.
18 Pandey V,Tiwari P,Sharma SP,et al.Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol[J].Int J Oral Maxillofac Surg,2018,47(7):908-912.DOI:10.1016/j.ijom.2018.03.024.
19 董娟,纪尧峰.超声引导下射频消融治疗婴幼儿腮腺血管瘤[J].临床小儿外科杂志,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.Dong J,Ji YF.Ultrasound-guided RFA for the treatment of parotid gland hemangioma in infants[J].J Clin Ped Sur,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.
20 向芳,丁媛,于世荣.595 nm脉冲染料激光治疗婴幼儿皮肤真性血管瘤疗效观察[J].实用皮肤病学杂志,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.Xiang F,Ding Y,Yu SR.Curative effect analysis of 595 nm pulsed dye laser in the treatment of infantile hemangioma[J].Journal of Practical Dermatology,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.
21 Chinnadurai S,Sathe NA,Surawicz T.Laser treatment of infantile hemangioma:A systematic review[J].Lasers Surg Med,2016,48(3):221-233.DOI:10.1002/lsm.22455.
22 Li DN,Gold MH,Sun ZS,et al.Treatment of infantile hemangioma with optimal pulse technology[J].J Cosmet Laser Ther,2010,12(3):145-150.DOI:10.3109/14764172.2010.487908.
23 Zhong SX,Tao YC,Zhou JF,et al.Infantile Hemangioma:Clinical characteristics and efficacy of treatment with the long-pulsed 1,064-nm neodymium-doped yttrium aluminum garnet Laser in 794 Chinese patients[J].Pediatr Dermatol,2015,32(4):495-500.DOI:10.1111/pde.12593.
24 Stier MF,Glick SA,Hirsch RJ.Laser treatment of pediatric vascular lesions:Port wine stains and hemangiomas[J].J Am Acad Dermato,2008,58(2):261-285.DOI:10.1016/j.jaad.2007.10.492.
25 Ali A,Aiman U,Haseen MA,et al.The effect of oral propranolol versus oral corticosteroids in management of pediatric hemangiomas[J].World J Plast Surg,2018,7(1):16-24.
26 Greene AK,Couto RA.Oral prednisolone for infantile hemangioma:efficacy and safety using a standardized treatment protocol[J].Plast Reconstr Surg,2011,128(3):743-752.DOI:10.1097/PRS.0b013e3182221398.
27 Laken PA.Infantile hemangiomas:pathogenesis and review of propranolol use[J].Adv Neonatal Care,2016,16(2):135-142.DOI:10.1097/ANC.0000000000000254.
28 Liu X,Qu X,Zheng J,et al.Effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas:a meta-analysis[J].Plos One,2015,10(9):e0138100.DOI:10.1371/journal.pone.0138100.
29 Krowchuk DP,Frieden IJ,Mancini AJ,et al.Clinical Practice Guideline for the Management of Infantile Hemangiomas[J].Pediatr,2019,143(1):e20183475.DOI:10.1542/peds.2018-3475.
30 Oksiuta M,Matuszczak E,Debek W,et al.Treatment of problematic infantile hemangiomas with propranolol:a series of 40 cases and review of the literature[J].Postepy Hig Med Dosw,2014,68:1138-1344.DOI:10.5604/17322693.1120990.
31 Gonzalez-Llorente N,Del OI,Munoz-Ollero N,et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol,2017,34(5):554-558.DOI:10.1111/pde.13229.
32 Hoeger PH,Harper JI,Baselga E,et al.Treatment of infantile haemangiomas:recommendations of a European expert group[J].Eur J Pediatr,2015,174(7):855-865.DOI:10.1007/s00431-015-2570-0.
33 郑家伟,杨秀娟.血管瘤的治疗选择[J].中国实用口腔科杂志,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.Zheng JW,Yang XJ.Selection of treatment modalities for infantile hemangiomas[J].Chinese Journal of Practical Stomatology,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.
34 李田园,贾仁兵,范先群.婴幼儿眼部血管瘤的治疗进展[J].临床眼科杂志,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.Li TY,Jia RB,Fan XQ.Advances in the treatment of periorbital infantile hemangiomas[J].Journal of Clinical Ophthalmology,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.
35 Tangtatco JA,Freedman C,Phillips J,et al.Surgical treatment outcomes of infantile hemangioma in children:does prior medical treatment matter[J].Pediatr Dermatol,2018,35(6):e418-e419.DOI:10.1111/pde.13658.
36 Lou H,Xu G,Huo R.Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas[J].Exp Ther Med,2018,15(6):4677-4682.DOI:10.3892/etm.2018.6035.
37 Li S,Xu G,Gao F,et al.Expression and association of VEGF-Notch pathways in infantile hemangiomas[J].Exp Ther Med,2017,14(4):3737-3743.DOI:10.3892/etm.2017.4943.
38 Bayart CB,Tamburro JE,Vidimos AT,et al.Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase:a retrospective noninferiority study[J].Pediatr Dermatol,2017,34(4):413-421.DOI:10.1111/pde.13177.

Memo

收稿日期:2018-12-18。
通讯作者:郭晓东,Emali:guoxiaodong@zju.edu.cn

Last Update: 1900-01-01